A Study Assessing the Safety and Effectiveness of FEX60/PE10 Fixed Combination Tablet in Patients With Allergic Rhinitis
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
Primary Objective:
To assess the safety of twice-daily fexofenadine 60 mg/phenylephrine 10 mg (FEX60/PE10)
combination tablet in patients with allergic rhinitis.
Secondary Objective:
To evaluate the effectiveness of a twice-daily FEX60/PE10 combination tablet on nasal
symptoms (sneezing, rhinorrhea, and nasal congestion), and daily activity impairment.